Mallory Haglund, in Boulder, NV - Psychologist

Mallory Haglund, is a Psychologist - Addiction (substance Use Disorder) based in Boulder, Nevada. Mallory Haglund is licensed to practice in * (Not Available) (license number ) and her current practice location is 284 West Rocky Lane, Boulder, Nevada. She can be reached at her office (for appointments etc.) via phone at (681) 664-5541.

NPI number for Mallory Haglund is 1679949358 and her current mailing address is 3850 Las Vegas Blvd S, Las Vegas, Nevada. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1679949358.

Contact Information

	Mallory Haglund,
	284 West Rocky Lane, Boulder, NV 55114
	(681) 664-5541
	Not Available

Healthcare Provider's Profile

Full Name	Mallory Haglund
Gender	Female
Speciality	Psychologist - Addiction (substance Use Disorder)
Location	284 West Rocky Lane, Boulder, Nevada
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1679949358
Provider Enumeration Date: 08/17/2015
Last Update Date: 07/18/2018

Medical Identifiers

Medical identifiers for Mallory Haglund such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1679949358	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
101YM0800X	Counselor - Mental Health	1125 (Nevada)	Secondary
103TA0400X	Psychologist - Addiction (substance Use Disorder)	(* (Not Available))	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mallory Haglund is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Mallory Haglund, 3850 Las Vegas Blvd S, Las Vegas, NV 89109-4324 Ph: () -	Mallory Haglund, 284 West Rocky Lane, Boulder, NV 55114 Ph: (681) 664-5541

News Archive

HHS awards a five-year $2 million grant to BayCare Behavioral Health

BayCare Behavioral Health and the Homeless Emergency Project have received a five-year grant of $400,000 for each year for a total of $2 million from the U.S. Department of Health and Human Services Substance Abuse and Mental Health Services Administration (SAMHSA) Center for Substance Abuse Treatment (CSAT).

Scientists identify molecules that block accumulation of toxic eye protein responsible for early onset of glaucoma

Using a novel high-throughput screening process, scientists have for the first time identified molecules with the potential to block the accumulation of a toxic eye protein that can lead to early onset of glaucoma.

Researchers publish first comprehensive characterization of genetic diversity in Sub-Saharan Africa

Researchers from the African Genome Variation Project have published the first attempt to comprehensively characterise genetic diversity across Sub-Saharan Africa. The study of the world's most genetically diverse region will provide an invaluable resource for medical researchers and provides insights into population movements over thousands of years of African history.

Study: Hormone-therapy-related breast cancer cells can be attacked by cancer therapies

More than 100 women per day die from breast cancer in the United States. The odds of developing breast cancer increase for women taking hormone replacement therapy to avoid the effects of menopause.

Emergence of drug resistance to ARVs has potential to 'curb, and even reverse' gains against HIV

Noting that the "roll-out of antiretroviral treatment for HIV in sub-Saharan Africa has been accompanied by rising rates of drug resistance," Raph Hamers, a global health research fellow at the Academic Medical Centre of the University of Amsterdam, and colleagues "call for improved patient management and the integration of population-based drug resistance surveillance into national treatment programs" in this BMJ analysis.

Mallory Haglund, - Counselor in Boulder, NV